Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
42 Leser
Artikel bewerten:
(0)

Pacific Exchange(R) to Trade Seven New Options


SAN FRANCISCO, Jan. 12 /PRNewswire-FirstCall/ -- The Pacific Exchange, Inc. ("PCX") announced that at the opening of business on Thursday, January 12, 2006, it will commence trading options on the following equity securities: BCE, Inc. ; Berry Grupo Televisa S.A. ; Martin Marietta Inc. ; Pain Therapeutics, Inc. ; SIFY Ltd. - S.A. ; Spectrum Pharmaceuticals, Inc. ; Stamps.com, Inc. .

BCE options will trade on the March expiration cycle with exercise limits set at 7,500,000 shares. The issue will be traded by lead market makers Joshua Reider and Marcus Nilsson of Citadel Derivatives Group, LLC.

Grupo Televisa S.A. options will trade on the January expiration cycle with exercise limits set at 20,000,000 shares. The issue will be traded by lead market makers Ross Goodheart, Ken Keating and Bartev Vartanian of Group One Trading, LP.

Martin Marietta options will trade on the January expiration cycle with exercise limits set at 7,500,000 shares. The issue will be traded by lead market maker Catherine Clay of Timber Hill, LLC.

Pain Therapeutics options will trade on the January expiration cycle with exercise limits set at 5,000,000 shares. The issue will be traded by lead market maker Kurt Eckert of Wolverine Trading, LLC.

SIFY Ltd options will trade on the March expiration cycle with exercise limits set at 20,000,000 shares. The issue will be traded by lead market makers Ross Goodheart, Ken Keating and Bartev Vartanian of Group One Trading, LP.

Spectrum Pharmaceuticals options will trade on the February expiration cycle with exercise limits set at 2,500,000 shares. The issue will be traded by lead market maker Kurt Eckert of Wolverine Trading, LLC.

Stamps.com options will trade on the February expiration cycle with exercise limits set at 7,500,000 shares. The issue will be traded by lead market makers Joshua Reider and Marcus Nilsson of Citadel Derivatives Group, LLC.

Forward-Looking Statements

Certain statements in this press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on Archipelago's current expectations and involve risks and uncertainties that could cause Archipelago's actual results to differ materially from those set forth in the statements. There can be no assurance that such expectations will prove to be correct. Factors that could cause Archipelago's results to differ materially from current expectations include: general economic and business conditions, industry trends, competitive conditions, regulatory developments as well as other risks or factors identified in the Company's filings with the Securities Exchange Commission, including its Report on Form 10-K for the fiscal year ending December 31, 2004 which is available on the Company's website at http://www.archipelago.com/. You should not place undue reliance on forward- looking statements, which speak only as of the date of this press release. Except for any obligation to disclose material information under the Federal securities laws, Archipelago undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this press release.

For more information contact Todd Swearingen, (312) 442-7747. tswearingen@archipelago.com
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2006 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.